Transformations were plated in solid BSK - II medium
containing 200 μg / ml kanamycin (transformation of B31 - A3), or 200 μg / ml kanamycin and 40 μg / ml
gentamicin (transformation of ospC7).
Active Ingredients (per gram):
Gentamicin sulfate, USP equivalent to 3 mg gentamicin base; betamethasone valerate, USP equivalent to 1 mg betamethasone; and 10 mg clotrimazole, USP in a mineral oil - based system containing a plasticized hydroc
Gentamicin sulfate, USP equivalent to 3 mg
gentamicin base; betamethasone valerate, USP equivalent to 1 mg betamethasone; and 10 mg clotrimazole, USP in a mineral oil - based system containing a plasticized hydroc
gentamicin base; betamethasone valerate, USP equivalent to 1 mg betamethasone; and 10 mg clotrimazole, USP in a mineral oil - based system
containing a plasticized hydrocarbon gel.